Clinical Trial Update: A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) [Phase 1]

View source ↗

Summary

Dizal Pharmaceuticals is conducting a Phase 1 mass-balance pharmacokinetic study of DZD8586 in healthy male participants (TAI-SHAN15); the trial is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• DZD8586

Snippet

Sponsor: Dizal Pharmaceuticals | Conditions: Lymphoma, Non-Hodgkin | Phase 1 | Status: NOT_YET_RECRUITING